DrugPatentWatch Database Preview
Ferric citrate - Generic Drug Details
» See Plans and Pricing
What are the generic drug sources for ferric citrate and what is the scope of freedom to operate?
Ferric citrate
is the generic ingredient in one branded drug marketed by Keryx Biopharms and is included in one NDA. There are fifteen patents protecting this compound. Additional information is available in the individual branded drug profile pages.Ferric citrate has one hundred and thirty-three patent family members in twenty-six countries.
There are twenty drug master file entries for ferric citrate.
Summary for ferric citrate
| International Patents: | 133 |
| US Patents: | 15 |
| Tradenames: | 1 |
| Applicants: | 1 |
| NDAs: | 1 |
| Drug Master File Entries: | 20 |
| Bulk Api Vendors: | 41 |
| Clinical Trials: | 28 |
| Patent Applications: | 3 |
| Formulation / Manufacturing: | see details |
| Patent Litigation and PTAB cases: | See patent lawsuits and PTAB cases for ferric citrate |
| DailyMed Link: | ferric citrate at DailyMed |
Recent Clinical Trials for ferric citrate
Identify potential brand extensions & 505(b)(2) entrants
| Sponsor | Phase |
|---|---|
| Rockwell Medical Technologies, Inc. | Phase 3 |
| Shandong Weigao Panion Pharmaceutical Co. Ltd. | Phase 3 |
| Sinomune Pharmaceutical Co., Ltd | Phase 3 |
US Patents and Regulatory Information for ferric citrate
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Keryx Biopharms | AURYXIA | ferric citrate | TABLET;ORAL | 205874-001 | Sep 5, 2014 | RX | Yes | Yes | Start Trial | Start Trial | Y | Y | Start Trial | ||
| Keryx Biopharms | AURYXIA | ferric citrate | TABLET;ORAL | 205874-001 | Sep 5, 2014 | RX | Yes | Yes | Start Trial | Start Trial | Start Trial | ||||
| Keryx Biopharms | AURYXIA | ferric citrate | TABLET;ORAL | 205874-001 | Sep 5, 2014 | RX | Yes | Yes | Start Trial | Start Trial | Y | Start Trial | |||
| Keryx Biopharms | AURYXIA | ferric citrate | TABLET;ORAL | 205874-001 | Sep 5, 2014 | RX | Yes | Yes | Start Trial | Start Trial | Y | Y | Start Trial | ||
| Keryx Biopharms | AURYXIA | ferric citrate | TABLET;ORAL | 205874-001 | Sep 5, 2014 | RX | Yes | Yes | Start Trial | Start Trial | Y | Start Trial | |||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
International Patents for ferric citrate
| Country | Patent Number | Estimated Expiration |
|---|---|---|
| Taiwan | I335218 | Start Trial |
| China | 105616397 | Start Trial |
| Japan | 2001506262 | Start Trial |
| Norway | 327148 | Start Trial |
| Israel | 193099 | Start Trial |
| >Country | >Patent Number | >Estimated Expiration |
